Replies to post #567027 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

horrific QOL

Horrific? Grade 3 skin involvement occurred (from memory) in 2-3% of patients.

with dubious benefit.

It improved both PFS and OS.

[iclight]

Horrific QOL?

Nope. Don't facts get in the way of fear mongering:

The addition of TTFields to standard treatment with temozolomide for patients with glioblastoma results in improved survival without a negative influence on HRQoL except for more itchy skin, an expected consequence from the transducer arrays.